DK326781A - Fremgangsmaade til fremstilling af hepatitis a virus - Google Patents

Fremgangsmaade til fremstilling af hepatitis a virus

Info

Publication number
DK326781A
DK326781A DK326781A DK326781A DK326781A DK 326781 A DK326781 A DK 326781A DK 326781 A DK326781 A DK 326781A DK 326781 A DK326781 A DK 326781A DK 326781 A DK326781 A DK 326781A
Authority
DK
Denmark
Prior art keywords
virus
hepatitis
preparing hepatitis
preparing
hav
Prior art date
Application number
DK326781A
Other languages
Danish (da)
English (en)
Inventor
H Z Markus
W J Mcaleer
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK326781A publication Critical patent/DK326781A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32451—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK326781A 1980-07-23 1981-07-22 Fremgangsmaade til fremstilling af hepatitis a virus DK326781A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/171,621 US4301249A (en) 1980-07-23 1980-07-23 High titer production of hepatitis A virus

Publications (1)

Publication Number Publication Date
DK326781A true DK326781A (da) 1982-01-24

Family

ID=22624494

Family Applications (1)

Application Number Title Priority Date Filing Date
DK326781A DK326781A (da) 1980-07-23 1981-07-22 Fremgangsmaade til fremstilling af hepatitis a virus

Country Status (11)

Country Link
US (1) US4301249A (cg-RX-API-DMAC7.html)
EP (1) EP0044793B1 (cg-RX-API-DMAC7.html)
JP (1) JPS5753410A (cg-RX-API-DMAC7.html)
AT (1) ATE20250T1 (cg-RX-API-DMAC7.html)
CA (1) CA1187413A (cg-RX-API-DMAC7.html)
DE (1) DE3174765D1 (cg-RX-API-DMAC7.html)
DK (1) DK326781A (cg-RX-API-DMAC7.html)
ES (1) ES504199A0 (cg-RX-API-DMAC7.html)
GR (1) GR74594B (cg-RX-API-DMAC7.html)
IE (1) IE51454B1 (cg-RX-API-DMAC7.html)
PT (1) PT73371B (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783407A (en) * 1985-09-30 1988-11-08 Merck & Co., Inc. Growth of hepatitus A virus in vero cells
DE3633550A1 (de) * 1986-10-02 1988-04-14 Behringwerke Ag Vaccine gegen hepatitis a
US5268292A (en) * 1988-06-27 1993-12-07 Robertson Betty H Reproducible generation of high yields of hepatitis A virus by cell culture
AU650711B2 (en) * 1990-12-13 1994-06-30 Cellco, Inc. Sustained and continuous production of high titers of recombinant viral vectors and transduced target cells for use in gene therapy
US5506129A (en) * 1991-05-24 1996-04-09 Evans Medical Limited Virus production
DZ1706A1 (fr) * 1992-08-07 2002-02-17 Merck & Co Inc Vaccin contre le virus de l'hepatite a.
US5354692A (en) * 1992-09-08 1994-10-11 Pacific Biotech, Inc. Analyte detection device including a hydrophobic barrier for improved fluid flow
HRP950097A2 (en) * 1994-03-08 1997-06-30 Merck & Co Inc Hepatitis a virus culture process
US5498537A (en) * 1994-03-09 1996-03-12 Cellco, Inc. Serum-free production of packaged viral vector
US20020182730A1 (en) * 1995-07-26 2002-12-05 Micheal L. Gruenberg Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
FR2821947B1 (fr) * 2001-03-12 2003-05-16 Canon Kk Procede et dispositif de validation de parametres definissant une image
US20030134415A1 (en) * 2001-09-19 2003-07-17 Gruenberg Micheal L. Th1 cell adoptive immunotherapy
US20030134341A1 (en) * 2001-09-19 2003-07-17 Medcell Biologics, Llc. Th1 cell adoptive immunotherapy
US20030175272A1 (en) * 2002-03-07 2003-09-18 Medcell Biologics, Inc. Re-activated T-cells for adoptive immunotherapy
EP1497444B1 (en) * 2002-03-27 2015-11-04 Immunex Corporation Methods for increasing polypeptide production
US20100028973A1 (en) * 2006-09-26 2010-02-04 Kyoto University Method for proliferating hepatitis virus, hollow fiber for culturing hepatitis virus-infected cells, and use thereof
MX2009011899A (es) * 2007-05-04 2010-03-30 Baxter Int Perfil de temperatura de dos pasos para la propagacion de virus.
JP5692688B2 (ja) * 2008-06-26 2015-04-01 東洋紡株式会社 感染性ｃ型肝炎ウイルス粒子の製造方法、およびその利用
WO2012122625A1 (en) 2011-03-14 2012-09-20 National Research Council Of Canada Method of viral production in cells

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3615024A (en) * 1968-08-26 1971-10-26 Amicon Corp High flow membrane
US3821087A (en) * 1972-05-18 1974-06-28 Dedrick R Cell culture on semi-permeable tubular membranes
US3883393A (en) * 1972-05-18 1975-05-13 Us Health Education & Welfare Cell culture on semi-permeable tubular membranes
US3997396A (en) * 1973-07-02 1976-12-14 Monsanto Company Method for the in vitro propagation and maintenance of cells
US4087327A (en) * 1976-04-12 1978-05-02 Monsanto Company Mammalion cell culture process
FR2398504A1 (fr) 1977-07-29 1979-02-23 Tours Inst Virologie Culture de virus de l'hepatite a, in vitro. application a la production d'un antigene reactif, d'immunserums specifiques et de vaccins contre l'hepatite a
US4164566A (en) * 1978-08-17 1979-08-14 Merck & Co., Inc. Hepatitis a virus cell culture in vitro
US4301250A (en) * 1979-11-02 1981-11-17 Merck & Co., Inc. Method of producing hepatitis B surface antigen

Also Published As

Publication number Publication date
JPS5753410A (en) 1982-03-30
CA1187413A (en) 1985-05-21
GR74594B (cg-RX-API-DMAC7.html) 1984-06-29
EP0044793A2 (en) 1982-01-27
IE51454B1 (en) 1986-12-24
PT73371A (en) 1981-08-01
ES8205016A1 (es) 1982-05-16
PT73371B (en) 1983-06-15
US4301249A (en) 1981-11-17
IE811655L (en) 1982-01-23
DE3174765D1 (en) 1986-07-10
ATE20250T1 (de) 1986-06-15
EP0044793B1 (en) 1986-06-04
ES504199A0 (es) 1982-05-16
EP0044793A3 (en) 1983-01-05

Similar Documents

Publication Publication Date Title
DK326781A (da) Fremgangsmaade til fremstilling af hepatitis a virus
DK437988A (da) Fremgangsmaade til rensning af hepatitis a vironer
DK643387A (da) T-celle-epitoper af hepatitis b-virus-nucleocapsid-protein
DK0414475T3 (da) Fremgangsmåder til dyrkning af HCV i B- eller T-lymfocyt-cellelinier
KR870007282A (ko) 효모에서 b형 간염 바이러스 단백질을 제조하는 방법
DK163133C (da) Biologisk ren praeparation af en smitsom bronchitis-virusstamme
ATE6402T1 (de) Verfahren zur herstellung von hepatitis b oberflaechenantigen.
ATE6201T1 (de) Verfahren zur lyophilisierung lebender viruszusammensetzungen.
DK49479A (da) Fremgangsmaade til fremstilling af vaccine samt fremgangsmaade til fremstilling af et antisof
DK372780A (da) Fremgangsmaade til propagering af humant hepatitis a virus
DK163067C (da) Biologisk ren praeparation af en smitsom bronkitis-virusstamme
ATE127526T1 (de) Verfahren zur herstellung von natürlichem hiv- glykoprotein 160.
DK215488D0 (da) Fremgangsmaade til fremstilling af kartoffelfibre og de derved fremstillede fibre
DK462280A (da) Fremgangsmaade til fremstilling af hepatitis b overfladeantigen
DK289378A (da) Fremgangsmaade til dyrkning af virus
DK365387D0 (da) Fremgangsmaade ved fremstilling af biogas
DK481385D0 (da) Fremgangsmaade til diskontinuerlig enzymatisk roedning af hoer eller andre roedningsegnede planter
BG28059A3 (en) Method of stereoselective obtaining of optical active transhexahydrobenzopyranones
DK0403015T3 (da) Fremgangsmåde til dyrkning af celler
DK190187D0 (da) Fremgangsmaade til fremstilling af n-aminophthalimid
ATE64187T1 (de) Lichtinstrument und verfahren zur erzeugung von lichtwirkungen.
SU1692146A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus l. - продуцент моноклональных антител к 146 s-компоненту вируса ящура o
DK382488D0 (da) Fremgangsmaade til paavisning af plantevirus
SE8601011D0 (sv) Forfarande och anordning for artificiell odling av plantor
DK372289A (da) Metode til praeparering af podestofsektioner til plantevaevskultur

Legal Events

Date Code Title Description
ATS Application withdrawn